Venture Life Buys Back Shares, Updates Voting Rights Total

Venture Life ( (GB:VLG) ) just unveiled an update.

Venture Life Group has repurchased 60,847 ordinary shares at a volume-weighted average price of 67.91 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 6,978,872 are held in treasury, leaving 121,881,273 voting rights outstanding, a figure shareholders can use to assess disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on VLG Stock

According to Spark, TipRanks’ AI Analyst, VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. Its portfolio includes brands such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her products for the hormonal lifecycle, sold via pharmacies, health and beauty retailers, grocery chains and e-commerce globally.

Average Trading Volume: 300,949

Technical Sentiment Signal: Buy

Current Market Cap: £82.92M

See more insights into VLG stock on TipRanks’ Stock Analysis page.